Eric Weisblum - Apr 28, 2020 Form 4/A - Amendment Insider Report for Silo Pharma, Inc. (SILO)

Role
CEO, CFO and President, Director
Signature
/s/ Eric Weisblum
Stock symbol
SILO
Transactions as of
Apr 28, 2020
Transactions value $
$0
Form type
4/A - Amendment
Date filed
5/17/2021, 07:33 AM
Date Of Original Report
Apr 30, 2020
Previous filing
May 17, 2021
Next filing
Dec 15, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SILO Common Stock Award +7.63M +13131% 7.69M Apr 28, 2020 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Issued to the Reporting Person pursuant to that certain Employment Agreement, dated April 17, 2020, by and between the Issuer and the Reporting Person.
F2 This Form 4 is being filed to amend the prior Form 4 filed by the Reporting Person on April 30, 2020, which erroneously included the Reporting Person's stock options in Column 5 of Table I.